Evidence map›Paper›PMID 40051514›Full record

SynthesisFrontiers in public health2025

Technological functionality and system architecture of mobile health interventions for diabetes management: a systematic review and meta-analysis of randomized controlled trials.

Xinran Yu, Yifeng Wang, Zhengyang Liu, Euitay Jung

Abstract readSystematic ReviewMeta-Analysis
In one paragraph

Synthesis in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Xinran YuGraduate School, Major of Visual Design, Hanyang University, Seoul, Republic of Korea.
Yifeng WangGraduate School, Major of Visual Design, Hanyang University, Seoul, Republic of Korea.
Zhengyang LiuSchool of Art, Shandong University of Finance and Economics, Jinan, Shandong, China.
Euitay JungGraduate School, Major of Visual Design, Hanyang University, Seoul, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Despite advancements in digital health, systematic evaluations of mobile applications (Apps) for diabetes management are limited. Methods: Researchers conducted searches on PUBMED, EMBASE, COCHRANE, SCOPUS, and WEB OF SCIENCE from inception to August 2024. The researchers included randomized controlled trials (RCTs) that investigated the effectiveness of app-based interventions in health management among diabetic patients. Reviewers were paired and independently conducted the screening of studies, data extraction, and evaluation of study quality. The primary outcome of interest was the modification of hemoglobin A1c (HbA1c). The researchers utilized a random effects model to calculate the weighted mean differences (WMDs) and 95% confidence intervals (CIs) and used the I Results: 41 studies of 3911 initially identified articles that met the selection criteria. The results showed that Apps' intervention significantly improved glycemic control in diabetic patients, with a mean reduction in HbA1c levels of 0.49% (95%CI: -0.65 to -0.32%) compared to standard care. The analysis also revealed that Apps enhanced patient self-management behaviors. Subgroup analyses failed to resolve heterogeneity, but studies consistently observed improved HbA1c levels. The quality assessment results indicated that most studies performed well in the completeness of outcome data and selective reporting. Discussion: This meta-analysis confirms that mobile health applications with practical technological functionalities and system architectures are beneficial in managing diabetes. These applications significantly reduced HbA1c levels and improved self-management behaviors. Although some studies exhibited a moderate risk of bias, the overall evidence supports using these applications as valuable tools in diabetes care. Future research should standardize application features, refine system architectures, and address bias issues to enhance. Systematic Review Registration: PROSPERO (CRD42023441365).

Indexed as

Diabetes MellitusMobile ApplicationsTelemedicineGlycated HemoglobinHumansRandomized Controlled Trials as TopicGlycated Hemoglobindiabetes managementmeta-analysismobile applicationsrandom controlled trialssystem architecture

Identifiers

PMID40051514
PMCPMC11884075

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.